A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

Most states allow some form of "medical marijuana." It is especially popular with pain patients, many of whom do not have ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...

Less than 3% of all prescriptions involved opioids, the study found, and more than 90% of players never received an opioid for their pain.

The FDA-approved medication, available as a 50-milligram prescription tablet taken every 12 hours, offers a non-opioid alternative for pain management. While the company asserts that the cost is ...

A new opioid-free pain medication was approved by the U.S ... In 2023, more than five million Americans 12 and older reported a "prescription use disorder" within the past year, according to ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...